Brain Tumour Conference: Speakers

Brain 2020 conference hero image

Brain Tumour Conference 2020


Last updated 13 March, 2020

Important information regarding your registration at the Brain Tumour Conference 2020

Cancer Research UK have been closely monitoring developments relating to the coronavirus (COVID-19) outbreak and reviewing guidance from government bodies.  After careful consideration we have taken the decision not to go ahead as planned, with the Brain Tumour Conference scheduled for 12-14 May 2020.

With the number of attendees, including those travelling internationally, and given that many of you work with vulnerable communities, we agreed that safeguarding your health and safety, and the health and safety of those you work with, is our priority. With global restrictions on international travel continuing to grow, it would not be possible to hold the event in its current format without impacting on the quality of the sessions.

Please review our cancellation policy below. If you have any questions please email

Important cancellation information

All cancellations must be made in writing to We do not accept telephone cancellations.

All registrants are eligible for a full refund of their ticket. If we do not receive a cancellation email, your booking will automatically be transferred to the rescheduled date. If you are unable to attend the rescheduled meeting, please email to request a full refund.

Cancer Research UK are not liable for any travel or accommodation costs relating to attendee bookings.

Poster and proffered talks

Once a new date for the conference has been confirmed, we ask you to resubmit your abstract for consideration.

Further details of our programme of speakers will be confimed throughout the winter. For details on sesson topics - head over to the programme tab.

Contact us

If you need more information on the event please contact us:

Sponsors and exhibitors


Aurora Callaghan
Research Events Manager
Tel +44 (0)203 469 6348

Research opportunities in brain tumours

[Brain icon]

Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".

We're boosting our investment into brain tumours, and we have a number of opportunities to help you develop your brain tumour research or to apply your skills to these cancers for the first time.